Recent research has illuminated the expanding potential of drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, which were initially approved for diabetes management...
By 193cc Agency CouncilSeptember 5, 2024Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for weight loss and diabetes management, are now being investigated for their potential...
By 193cc Agency CouncilJuly 16, 2024